immunity · Mechanism Report
Does iron deficiency impair immune function and raise infection risk?
Iron deficiency impairs innate and adaptive immune functions and is associated with increased susceptibility to infections.
This is what AI claimed
Iron deficiency can impair immune function and increase susceptibility to infections.
Executive summary
The claim states that lack of iron limits key enzymatic processes needed for lymphocyte proliferation and for microbial killing by innate cells, producing a state of immune impairment. The mechanism links reduced ribonucleotide reductase and other iron-dependent enzymes to stalled T‑cell expansion and weakened oxidative killing, which in turn increases the likelihood of clinical infections and reactivation of latent pathogens.
Verified conclusion
Iron is a fundamental micronutrient that acts as a critical cofactor for enzymes involved in DNA synthesis, cellular metabolism, and the antimicrobial response. Its deficiency creates a state of metabolic constraint that compromises both the innate and adaptive immune systems.
Clinical evidence and effectiveness
Clinical observations consistently link iron deficiency to a heightened risk of morbidity from infections, particularly in respiratory and gastrointestinal domains.
- Lymphocyte Response: Research indicates that iron-deficient individuals often exhibit reduced T-cell counts and impaired delayed-type hypersensitivity responses. This is primarily due to the inability of lymphocytes to expand rapidly enough to mount an effective defense during a pathogen challenge.
- Epidemiological Links: Large-scale studies show that correcting iron deficiency can reduce the frequency and severity of infections in vulnerable populations, such as children and women of reproductive age.
- Risk Complexity: While deficiency impairs the host, it is important to note that many pathogens also require iron to replicate. Consequently, the relationship between iron status and infection is a "double-edged sword," where both extreme deficiency and excessive iron availability (particularly non-transferrin-bound iron) can negatively influence infection outcomes.
Mechanistic explanations
The immune impairment seen in iron deficiency is driven by specific cellular and molecular failures:
- DNA Synthesis: Ribonucleotide reductase, the enzyme responsible for the rate-limiting step in DNA synthesis, requires a diferric-tyrosyl radical cofactor. When iron is scarce, this enzyme's activity drops, directly stalling the proliferation of T-lymphocytes.
- Oxidative Killing: Neutrophils and macrophages rely on iron-containing enzymes, such as myeloperoxidase (MPO), to produce the "oxidative burst" (reactive oxygen species) necessary to kill phagocytosed bacteria.
- Cellular Signaling: Iron deficiency disrupts the functional polarization of macrophages, reducing their ability to present antigens via MHC class II and diminishing the production of critical cytokines like interferon-gamma, which are essential for antiviral responses.
Bottom line
Iron deficiency significantly impairs immune function by stalling lymphocyte proliferation and weakening the bactericidal activity of innate immune cells. While this mechanistically increases susceptibility to various infections, clinical management must balance correcting deficiency with the risk that excess iron can also promote pathogen growth.
References
- Iron and Immunity: Immunological Consequences of Iron Deficiency and Overload — pmc.ncbi.nlm.nih.gov
- The yeast Aft1 transcription factor activates ribonucleotide reductase catalytic subunit RNR1 in response to iron deficiency. — linkinghub.elsevier.com
- Iron Chelation Reinforces DNA Damage Response and Leads to G2/M Checkpoint Activation and Autophagy in Myeloid Bone Marrow Cells of Preleukemia Mouse Model — ashpublications.org
- The role of iron homeostasis in remodeling immune function and regulating inflammatory disease. — linkinghub.elsevier.com
- Iron Metabolism and Immune Regulation — pmc.ncbi.nlm.nih.gov
- The critical role of ferroptosis in virus-associated hematologic malignancies and its potential value in antiviral-antitumor therapy — pmc.ncbi.nlm.nih.gov
- Epstein–Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19 — pmc.ncbi.nlm.nih.gov
- Risk of Infection Associated With Administration of Intravenous Iron — jamanetwork.com
- High incidence of Epstein–Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19 — pmc.ncbi.nlm.nih.gov
- Regulation of ribonucleotide reductase in response to iron deficiency. — pmc.ncbi.nlm.nih.gov
- Non-Anemic Iron Deficiency Predicts COPD Exacerbations and Hospitalizations: Results from a Prospective Cohort — mdpi.com
See a full patient report verified like this
Book a walkthrough